Free Trial

IB Acquisition (IBAC) Competitors

$9.98
0.00 (0.00%)
(As of 02:52 PM ET)

IBAC vs. VINP, PUYI, BIOX, PKST, LAND, FPI, CHCT, ANSC, NLOP, and CTO

Should you be buying IB Acquisition stock or one of its competitors? The main competitors of IB Acquisition include Vinci Partners Investments (VINP), Highest Performances (PUYI), Bioceres Crop Solutions (BIOX), Peakstone Realty Trust (PKST), Gladstone Land (LAND), Farmland Partners (FPI), Community Healthcare Trust (CHCT), Agriculture & Natural Solutions Acquisition (ANSC), Net Lease Office Properties (NLOP), and CTO Realty Growth (CTO). These companies are all part of the "trading" industry.

IB Acquisition vs.

Vinci Partners Investments (NASDAQ:VINP) and IB Acquisition (NASDAQ:IBAC) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

In the previous week, Vinci Partners Investments had 1 more articles in the media than IB Acquisition. MarketBeat recorded 2 mentions for Vinci Partners Investments and 1 mentions for IB Acquisition. IB Acquisition's average media sentiment score of 1.84 beat Vinci Partners Investments' score of 1.78 indicating that IB Acquisition is being referred to more favorably in the news media.

Company Overall Sentiment
Vinci Partners Investments Very Positive
IB Acquisition Very Positive

Vinci Partners Investments has higher revenue and earnings than IB Acquisition.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vinci Partners Investments$591.93M0.91$44.19M$0.8112.42
IB AcquisitionN/AN/AN/AN/AN/A

Vinci Partners Investments has a net margin of 36.07% compared to IB Acquisition's net margin of 0.00%. Vinci Partners Investments' return on equity of 13.37% beat IB Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Vinci Partners Investments36.07% 13.37% 8.26%
IB Acquisition N/A N/A N/A

Vinci Partners Investments currently has a consensus target price of $14.50, suggesting a potential upside of 44.14%. Given Vinci Partners Investments' higher possible upside, equities analysts plainly believe Vinci Partners Investments is more favorable than IB Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vinci Partners Investments
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
IB Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

34.1% of Vinci Partners Investments shares are held by institutional investors. 49.3% of Vinci Partners Investments shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Vinci Partners Investments received 19 more outperform votes than IB Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
Vinci Partners InvestmentsOutperform Votes
19
61.29%
Underperform Votes
12
38.71%
IB AcquisitionN/AN/A

Summary

Vinci Partners Investments beats IB Acquisition on 10 of the 11 factors compared between the two stocks.

Get IB Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for IBAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IBAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IBAC vs. The Competition

MetricIB Acquisition IndustryUnclassified SectorNASDAQ Exchange
Market Cap$137.14M$2.08B$125.72M$8.20B
Dividend YieldN/A15.09%N/A4.09%
P/E RatioN/A10.6212.5518.35
Price / SalesN/A159.7610.5668.31
Price / CashN/A89.6582.7631.78
Price / BookN/A1.27525.104.61
Net IncomeN/A$81.10M$1.98M$222.74M
7 Day Performance-0.60%3.50%50.75%6.16%
1 Month Performance-0.30%1.79%58.59%9.68%
1 Year PerformanceN/A11.15%36.60%12.95%

IB Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VINP
Vinci Partners Investments
4.4636 of 5 stars
4.46 / 5 stars
$10.08
+1.4%
$14.50
+43.8%
-7.3%$542.10M$91.03M12.44240Positive News
PUYI
Highest Performances
0 of 5 stars
0.00 / 5 stars
$0.85
-8.6%
N/A-83.4%$540.47M$114.44M0.00550Gap Up
High Trading Volume
BIOX
Bioceres Crop Solutions
3.4006 of 5 stars
3.40 / 5 stars
$8.56
-0.5%
$13.63
+59.2%
-23.6%$537.57M$464.80M856.00500Earnings Report
Short Interest ↑
Analyst Revision
PKST
Peakstone Realty Trust
0.1243 of 5 stars
0.12 / 5 stars
$14.71
+5.9%
$13.00
-11.6%
-24.1%$535.15M$254.28M-0.9535
LAND
Gladstone Land
1.9898 of 5 stars
1.99 / 5 stars
$14.82
+2.4%
$16.00
+8.0%
-2.9%$531.15M$90.40M247.0470Short Interest ↓
News Coverage
Positive News
FPI
Farmland Partners
3.0908 of 5 stars
3.09 / 5 stars
$10.76
+3.4%
$15.00
+39.4%
+0.7%$518.31M$57.47M21.1030Short Interest ↑
News Coverage
CHCT
Community Healthcare Trust
3.7891 of 5 stars
3.79 / 5 stars
$17.37
+5.0%
$21.50
+23.8%
-46.7%$487.40M$112.85M27.1430Analyst Upgrade
Options Volume
Gap Up
ANSC
Agriculture & Natural Solutions Acquisition
0 of 5 stars
0.00 / 5 stars
$10.35
flat
N/AN/A$446.08MN/A0.00N/APositive News
NLOP
Net Lease Office Properties
0.9608 of 5 stars
0.96 / 5 stars
$30.00
+2.5%
$46.00
+53.3%
N/A$443.40M$174.96M0.00N/ANews Coverage
CTO
CTO Realty Growth
3.666 of 5 stars
3.67 / 5 stars
$19.07
+0.8%
$20.33
+6.6%
+13.3%$440.90M$109.12M34.6730Gap Down
High Trading Volume

Related Companies and Tools

This page (NASDAQ:IBAC) was last updated on 9/16/2024 by MarketBeat.com Staff

From Our Partners